CWM
HZNP

CIBC World Markets’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

CIBC World Markets’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-19,200
Closed -$2.22M – 783
2023
Q3 		$2.22M Buy
+19,200
New +$2.06M 0.02% 358

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

CIBC World Markets's HZNP Position: Q4 2023 in Review

CIBC World Markets sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 19,200 shares — an estimated $2.22M sold.

CIBC World Markets first reported a position in HZNP in Q3 2023 and held it in 1 quarter. The position peaked at $2.22M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • CIBC World Markets reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • CIBC World Markets sold 19,200 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.22M.
  • CIBC World Markets first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2023 and held it in 1 quarter.
  • CIBC World Markets's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.22M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on CIBC World Markets's 13F filing for Q4 2023, filed 13 Feb 2024.